Patient self-report for evaluating mild cognitive impairment and prodromal Alzheimer's disease.
Patient self-report for evaluating mild cognitive impairment and prodromal Alzheimer's disease.
复制标题
DOI:
10.1186/alzrt97
复制
发表时间:
2011-12-09
期刊:
影响因子:
--
通讯作者:
Cantillon M
中科院分区:
文献类型:
--
作者:
Frank L;Lenderking WR;Howard K;Cantillon M
Patient-reported outcome (PRO) measures are used to evaluate disease and treatments in many therapeutic areas, capturing relevant aspects of the disorder not obtainable through clinician or informant report, including those for which patients may have a greater level of awareness than those around them. Using PRO measures in mild cognitive impairment (MCI) and prodromal Alzheimer's disease (AD) presents challenges given the presence of cognitive impairment and loss of insight. This overview presents issues relevant to the value of patient report with emphasis on the role of insight. Complex activities of daily living functioning and executive functioning emerge as areas of particular promise for obtaining patient self-report. The full promise of patient self-report has yet to be realized in MCI and prodromal AD, however, in part because of lack of PRO measures developed specifically for mild disease, limited use of best practices in new measure development, and limited attention to psychometric evaluation. Resolving different diagnostic definitions and improving clinical understanding of MCI and prodromal AD will also be critical to the development and use of PRO measures.
登录
查看更多内容
影响因子:
5.4
作者:
Clare, Linda;Rowlands, Julia;Downs, Murna
通讯作者:
Downs, Murna
影响因子:
3.4
作者:
Aalten, P;Van Valen, E;Verhey, F
通讯作者:
Verhey, F
影响因子:
120.7
作者:
Ball, K;Berch, DB;Willis, SL
通讯作者:
Willis, SL
影响因子:
2.5
作者:
Banks, Sarah;Weintraub, Sandra
通讯作者:
Weintraub, Sandra
影响因子:
3.4
作者:
Cook, S.;Marsiske, M.
通讯作者:
Marsiske, M.